Aging and survival of cutaneous microvasculature

被引:46
作者
Chang, E
Yang, JW
Nagavarapu, U
Herron, GS [1 ]
机构
[1] Stanford Univ, Sch Med, Dept Dermatol, Stanford, CA 94305 USA
[2] Mol Med Res Inst, Sunnyvale, CA USA
关键词
endothelial cell; immortalization; in vivo angiogenesis model; telomerase;
D O I
10.1046/j.1523-1747.2002.01714.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
The growth and turnover of blood vessels in the skin is fundamental in normal development, wound repair, hair follicle cycling, tumor cell metastasis, and in many different states of cutaneous pathology. Whereas many investigations are focused on mechanisms of angiogenesis in the skin, the influence of cellular aging and replicative senescence (i.e., the inability, after a critical number of population doublings, to replicate) on microvascular remodeling events has received relatively less attention. In this article, we review the clinical and pathologic relationships associated with cutaneous vascular aging and update current knowledge of endothelial cell survival characteristics. A hypothesis is presented in which endothelial cell aging and survival are linked to molecular mechanisms controlling cell proliferation, quiescence, apoptosis, and cellular senescence. We review recent results demonstrating how activation of telomerase in human dermal microvascular endothelial cells affects their durability both in vitro and in vivo and conclude by linking these studies with current concepts involving endothelial cell precursors, control of postnatal somatic cell telomerase activity, and murine model systems.
引用
收藏
页码:752 / 758
页数:7
相关论文
共 123 条
  • [41] HAVLIK N, 1999, DERMATOLOGY GEN MED
  • [42] Herron GS, 1998, SEMIN CUTAN MED SURG, V17, P12
  • [43] HOLT DR, 1992, SURGERY, V112, P293
  • [44] Functional requirement of p23 and Hsp90 in telomerase complexes
    Holt, SE
    Aisner, DL
    Baur, J
    Tesmer, VM
    Dy, M
    Ouellette, M
    Trager, JB
    Morin, GB
    Toft, DO
    Shay, JW
    Wright, WE
    White, MA
    [J]. GENES & DEVELOPMENT, 1999, 13 (07) : 817 - 826
  • [45] SUPPRESSION OF CYCLIN D1 MESSENGER-RNA EXPRESSION BY THE ANGIOGENESIS INHIBITOR TNP-470 (AGM-1470) IN VASCULAR CELLS ENDOTHELIAL
    HORI, A
    IKEYAMA, S
    SUDO, K
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1994, 204 (03) : 1067 - 1073
  • [46] Hsiao RS, 1997, ANTICANCER RES, V17, P827
  • [47] CELL CYCLE-DEPENDENT NUCLEAR-LOCALIZATION OF EXOGENOUSLY ADDED FIBROBLAST GROWTH-FACTOR-I IN BALB/C 3T3 AND HUMAN VASCULAR ENDOTHELIAL-CELLS
    IMAMURA, T
    OKA, S
    TANAHASHI, T
    OKITA, Y
    [J]. EXPERIMENTAL CELL RESEARCH, 1994, 215 (02) : 363 - 372
  • [48] Ingber D E, 1992, Semin Cancer Biol, V3, P57
  • [49] Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization
    Isner, JM
    Asahara, T
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (09) : 1231 - 1236
  • [50] Telomerase expression in human somatic cells does not induce changes associated with a transformed phenotype
    Jiang, XR
    Jimenez, G
    Chang, E
    Frolkis, M
    Kusler, B
    Sage, M
    Beeche, M
    Bodnar, AG
    Wahl, GM
    Tlsty, TD
    Chiu, CP
    [J]. NATURE GENETICS, 1999, 21 (01) : 111 - 114